BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27516)

  • 1. Metabolism of prostacyclin in blood vessels.
    Wong PY; Sun FF; McGiff JC
    J Biol Chem; 1978 Aug; 253(16):5555-7. PubMed ID: 27516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An NADP-linked prostacyclin dehydrogenase in rabbit kidney.
    Korff JM; Jarabak J
    Prostaglandins; 1981 May; 21(5):719-25. PubMed ID: 7041194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of 6-ketoprostaglandin F1 alpha and prostacyclin to 6,15-diketo-13,14-dihydroprostaglandin F1 alpha-like material in cats and rabbits.
    Förstermann U; Neufang B; Hertting G
    Biochim Biophys Acta; 1982 Sep; 712(3):684-91. PubMed ID: 6751407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of prostacyclin: formation of an active metabolite in the liver.
    Wong PY; Lee WH; Quilley CP; McGiff JC
    Fed Proc; 1981 May; 40(7):2001-4. PubMed ID: 7014260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the mechanisms involved in the fate of prostacyclin (PGI2) and 6-keto-PGF1alpha in the pulmonary circulation.
    Hawkings HJ; Smith JB; Nicolaou KC; Eling TE
    Prostaglandins; 1978 Dec; 16(6):871-84. PubMed ID: 219443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 9-Hydroxyprostaglandin dehydrogenase in rat kidney cortex converts prostaglandin I2 into 15-keto-13,14-dihydro 6-ketoprostaglandin E1.
    Pace-Asciak CR; Domazet Z
    Biochim Biophys Acta; 1984 Nov; 796(2):129-35. PubMed ID: 6388642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of prostacyclin. III. Urinary metabolite profile of 6-keto PGF1 alpha in rat.
    Sun FF; Taylor BM; Sutter DM; Weeks JR
    Prostaglandins; 1979 May; 17(5):753-9. PubMed ID: 386428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary metabolism of prostacyclin (PGI2) in the rabbit.
    Wong PY; McGiff JC; Sun FF; Malik KU
    Biochem Biophys Res Commun; 1978 Jul; 83(2):731-8. PubMed ID: 29629
    [No Abstract]   [Full Text] [Related]  

  • 9. The human placental anti-aggregating factor is neither prostacyclin, nor a prostacyclin metabolite.
    Dembélé-Duchesne MJ; Thaler-Dao H; Chavis C; Crastes de Paulet A
    Prostaglandins; 1982 Nov; 24(5):701-14. PubMed ID: 6298904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of substrate specificities of the human placental NAD- and NADP-linked 15-hydroxyprostaglandin dehydrogenases.
    Jarabak J; Fried J
    Prostaglandins; 1979 Aug; 18(2):241-6. PubMed ID: 42948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation and elimination of prostacyclin metabolites in the cat in vivo as determined by radioimmunoassay of unextracted plasma.
    Machleidt C; Förstermann U; Anhut H; Hertting G
    Eur J Pharmacol; 1981 Aug; 74(1):19-26. PubMed ID: 7032951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of (5E)-6a-carbaprostaglandin I2 by rhesus monkey lung 15-OH prostaglandin dehydrogenase.
    McGuire JC; Morton DR; Brokaw FC; Sun FF
    Prostaglandins; 1981 Apr; 21(4):609-14. PubMed ID: 7019975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin metabolism in the fetal and maternal vasculature.
    Terragno NA; Terragno A
    Fed Proc; 1979 Jan; 38(1):75-7. PubMed ID: 759241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGI2 production by rat blood vessels: diminished prostacyclin formation in veins compared to arteries.
    Skidgel RA; Printz MP
    Prostaglandins; 1978 Jul; 16(1):1-16. PubMed ID: 360298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of prostacyclin by 9-hydroxyprostaglandin dehydrogenase in human platelets. Formation of a potent inhibitor of platelet aggregation and enzyme purification.
    Wong PY; Lee WH; Chao PH; Reiss RF; McGiff JC
    J Biol Chem; 1980 Oct; 255(19):9021-4. PubMed ID: 6997309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man.
    Rosenkranz B; Fischer C; Weimer KE; Frölich JC
    J Biol Chem; 1980 Nov; 255(21):10194-8. PubMed ID: 7000774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced prostacyclin availability of blood vessels in uraemic humans and rats.
    Leithner C; Winter M; Silbauer K; Wagner O; Pinggera W; Sinzinger H
    Proc Eur Dial Transplant Assoc; 1978; 15():418-23. PubMed ID: 368786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic disposition of prostacyclin in humans.
    Brash AR; Jackson EK; Saggese CA; Lawson JA; Oates JA; FitzGerald GA
    J Pharmacol Exp Ther; 1983 Jul; 226(1):78-87. PubMed ID: 6345756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man.
    Rosenkranz B; Fischer C; Reimann I; Weimer KE; Beck G; Frölich JC
    Artery; 1980; 8(1):18-22. PubMed ID: 7000039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the kidney in the metabolism of prostacyclin by the 15-hydroxyprostaglandin dehydrogenase pathway in vivo.
    Förstermann U; Neufang B
    Biochim Biophys Acta; 1984 May; 793(3):338-45. PubMed ID: 6370311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.